Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Nimotuzumab Combined With Radiotherapy and Concurrently Cisplatin in Patients With Stage IIB-IVA Cervical Squamous Cell Carcinoma

NCT03469531 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT03469531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Nimotuzumab Combined With Radiotherapy and Concurrently Cisplatin in Patients With Stage IIB-IVA Cervical Squamous Cell Carcinoma
Lead sponsor
Zhujiang Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 20, 2018
Completion date
December 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenosquamous cell carcinoma, cervical squamous cell carcinoma in situ, neoplasms, stage ib cervical cancer, stage iia cervical cancer, stage iib cervical cancer, stage iii cervical cancer, stage iva cervical cancer